TGFB1 and Hepatic fibrosis: A study by Yang et al. [40] reported significant reductions in ALT and AST levels following glycyrrhizin administration in diabetic rats, while Huo et al. [41] demonstrated that glycyrrhizin attenuates liver fibrosis by inhibiting TGF-β1 signaling.